These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 32998989)

  • 21. Efficacy of Hybrid Closed-Loop System in Adults with Type 1 Diabetes and Gastroparesis.
    Kaur H; Schneider N; Pyle L; Campbell K; Akturk HK; Shah VN
    Diabetes Technol Ther; 2019 Dec; 21(12):736-739. PubMed ID: 31347928
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Excellent Glycemic Control Maintained by Open-Source Hybrid Closed-Loop AndroidAPS During and After Sustained Physical Activity.
    Petruzelkova L; Soupal J; Plasova V; Jiranova P; Neuman V; Plachy L; Pruhova S; Sumnik Z; Obermannova B
    Diabetes Technol Ther; 2018 Nov; 20(11):744-750. PubMed ID: 30285476
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Safety and glycemic outcomes of do-it-yourself AndroidAPS hybrid closed-loop system in adults with type 1 diabetes.
    Gawrecki A; Zozulinska-Ziolkiewicz D; Michalak MA; Adamska A; Michalak M; Frackowiak U; Flotynska J; Pietrzak M; Czapla S; Gehr B; Araszkiewicz A
    PLoS One; 2021; 16(4):e0248965. PubMed ID: 33819289
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Six months of hybrid closed loop in the real-world: An evaluation of children and young adults using the 670G system.
    Berget C; Messer LH; Vigers T; Frohnert BI; Pyle L; Wadwa RP; Driscoll KA; Forlenza GP
    Pediatr Diabetes; 2020 Mar; 21(2):310-318. PubMed ID: 31837064
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Glycemic Outcomes of Use of CLC Versus PLGS in Type 1 Diabetes: A Randomized Controlled Trial.
    Brown SA; Beck RW; Raghinaru D; Buckingham BA; Laffel LM; Wadwa RP; Kudva YC; Levy CJ; Pinsker JE; Dassau E; Doyle FJ; Ambler-Osborn L; Anderson SM; Church MM; Ekhlaspour L; Forlenza GP; Levister C; Simha V; Breton MD; Kollman C; Lum JW; Kovatchev BP;
    Diabetes Care; 2020 Aug; 43(8):1822-1828. PubMed ID: 32471910
    [TBL] [Abstract][Full Text] [Related]  

  • 26. In-Clinic Evaluation of the MiniMed 670G System "Suspend Before Low" Feature in Children with Type 1 Diabetes.
    Wood MA; Shulman DI; Forlenza GP; Bode BW; Pinhas-Hamiel O; Buckingham BA; Kaiserman KB; Liljenquist DR; Bailey TS; Shin J; Huang S; Chen X; Cordero TL; Lee SW; Kaufman FR
    Diabetes Technol Ther; 2018 Nov; 20(11):731-737. PubMed ID: 30299976
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Optimizing Hybrid Closed-Loop Therapy in Adolescents and Emerging Adults Using the MiniMed 670G System.
    Messer LH; Forlenza GP; Sherr JL; Wadwa RP; Buckingham BA; Weinzimer SA; Maahs DM; Slover RH
    Diabetes Care; 2018 Apr; 41(4):789-796. PubMed ID: 29444895
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Glycemic control in people with type 1 diabetes using a hybrid closed loop system and followed by telemedicine during the COVID-19 pandemic in Italy.
    Longo M; Caruso P; Petrizzo M; Castaldo F; Sarnataro A; Gicchino M; Bellastella G; Esposito K; Maiorino MI
    Diabetes Res Clin Pract; 2020 Nov; 169():108440. PubMed ID: 32926958
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Assessment of the "Second Day" Exercise Effect on Glycemic Control, Insulin Requirements, and CHO Intake in Type 1 Diabetes Adults.
    Müller-Korbsch M; Frühwald L; Heer M; Fangmeyer-Binder M; Reinhart-Mikocki D; Fasching P
    J Diabetes Sci Technol; 2021 Jan; 15(1):127-133. PubMed ID: 31583900
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Multinational Home Use of Closed-Loop Control Is Safe and Effective.
    Anderson SM; Raghinaru D; Pinsker JE; Boscari F; Renard E; Buckingham BA; Nimri R; Doyle FJ; Brown SA; Keith-Hynes P; Breton MD; Chernavvsky D; Bevier WC; Bradley PK; Bruttomesso D; Del Favero S; Calore R; Cobelli C; Avogaro A; Farret A; Place J; Ly TT; Shanmugham S; Phillip M; Dassau E; Dasanayake IS; Kollman C; Lum JW; Beck RW; Kovatchev B;
    Diabetes Care; 2016 Jul; 39(7):1143-50. PubMed ID: 27208316
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Safety, efficacy and glucose turnover of reduced prandial boluses during closed-loop therapy in adolescents with type 1 diabetes: a randomized clinical trial.
    Elleri D; Biagioni M; Allen JM; Kumareswaran K; Leelarathna L; Caldwell K; Nodale M; Wilinska ME; Haidar A; Calhoun P; Kollman C; Jackson NC; Umpleby AM; Acerini CL; Dunger DB; Hovorka R
    Diabetes Obes Metab; 2015 Dec; 17(12):1173-9. PubMed ID: 26257323
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Day-and-Night Closed-Loop Insulin Delivery in a Broad Population of Pregnant Women With Type 1 Diabetes: A Randomized Controlled Crossover Trial.
    Stewart ZA; Wilinska ME; Hartnell S; O'Neil LK; Rayman G; Scott EM; Barnard K; Farrington C; Hovorka R; Murphy HR
    Diabetes Care; 2018 Jul; 41(7):1391-1399. PubMed ID: 29535135
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Performance of Omnipod Personalized Model Predictive Control Algorithm with Moderate Intensity Exercise in Adults with Type 1 Diabetes.
    Forlenza GP; Buckingham BA; Christiansen MP; Wadwa RP; Peyser TA; Lee JB; O'Connor J; Dassau E; Huyett LM; Layne JE; Ly TT
    Diabetes Technol Ther; 2019 May; 21(5):265-272. PubMed ID: 30925077
    [No Abstract]   [Full Text] [Related]  

  • 34. First Look at Control-IQ: A New-Generation Automated Insulin Delivery System.
    Brown S; Raghinaru D; Emory E; Kovatchev B
    Diabetes Care; 2018 Dec; 41(12):2634-2636. PubMed ID: 30305346
    [TBL] [Abstract][Full Text] [Related]  

  • 35. First year on commercial hybrid closed-loop system-experience on 111 children and adolescents with type 1 diabetes.
    Varimo T; Pulkkinen MA; Hakonen E; Hero M; Miettinen PJ; Tuomaala AK
    Pediatr Diabetes; 2021 Sep; 22(6):909-915. PubMed ID: 34015178
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Evaluating the Impact of Applying Personal Glucose Targets in a Closed-Loop System for People With Type 1 Diabetes.
    Fattah M; Boughton CK; Ware J; Allen JM; Hartnell S; Willinska ME; Thankamony A; de Beaufort C; Campbell FM; Fröhlich-Reiterer E; Hofer SE; Kapellen TM; Rami-Merhar B; Ghatak A; Randell TL; Besser REJ; Elleri D; Trevelyan N; Denvir Md L; Davis N; Bally L; Thabit H; Leelarathna L; Evans ML; Mader JK; Hovorka R
    J Diabetes Sci Technol; 2024 May; 18(3):695-700. PubMed ID: 36540007
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Closed-loop insulin delivery systems in patients with pancreatitis or pancreatectomy-induced diabetes: A case series.
    Touimer M; Charfi H; Sa Cunha A; Penfornis A; Amadou C
    Diabetes Metab; 2024 Jul; 50(4):101544. PubMed ID: 38788339
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Behavioral Patterns and Associations with Glucose Control During 12-Week Randomized Free-Living Clinical Trial of Day and Night Hybrid Closed-Loop Insulin Delivery in Adults with Type 1 Diabetes.
    Emami A; Willinska ME; Thabit H; Leelarathna L; Hartnell S; Dellweg S; Benesch C; Mader JK; Holzer M; Kojzar H; Pieber TR; Arnolds S; Evans ML; Hovorka R
    Diabetes Technol Ther; 2017 Jul; 19(7):433-437. PubMed ID: 28463010
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Diabetes distress and glycaemic control in young adults with type 1 diabetes: Associations by use of insulin pumps and continuous glucose monitors.
    Nagel KE; Dearth-Wesley T; Herman AN; Smith HG; Whitaker RC
    Diabet Med; 2021 Nov; 38(11):e14660. PubMed ID: 34309061
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Postprandial blood glucose control in type 1 diabetes for carbohydrates with varying glycemic index foods.
    Hashimoto S; Noguchi CC; Furutani E
    Annu Int Conf IEEE Eng Med Biol Soc; 2014; 2014():4835-8. PubMed ID: 25571074
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.